Velocity
This Week's Stories
Helios Intelligence

Helios Intelligence

Healthtech · Diagnostics · Longevity

Launch

Helios exits stealth with at-home blood test reading 1,000+ biomarkers

November 18, 2026

Serial biotech founders are betting proteomics can catch disease risk years before a standard checkup would.

  • Helios came out of stealth on November 18, 2026, opening a waitlist for an at-home blood test that measures over 1,000 proteins from a single drop of blood to flag disease risk and organ aging.
  • Founders Omar Abudayyeh and Jonathan Gootenberg invented the SHERLOCK CRISPR diagnostic and previously co-founded Sherlock Biosciences (acquired by OraSure) and Tome Biosciences (raised $200M+, shut down in 2024); physician-scientist Yousef Badran of MGH/Harvard rounds out the team.
  • Users self-collect blood with a painless, needle-free arm device and mail it to Helios's Boston lab, which scores 70+ organs and pathways and estimates risk for diseases like heart failure, blood cancers and Alzheimer's.
  • The full test and an accompanying AI Health Coach are slated to launch in 2027, first through longevity clinics and concierge doctors at $250–$600 per test, with direct-to-consumer sales targeted by late 2027.
  • Helios, founded 16 months ago, previously raised $2.3M in seed funding from Y Combinator, Formation VC and angel investors, which it disclosed alongside the stealth launch.
  • The founders registered the domain theranosbutworks.com, which redirects to Helios's site, leaning into inevitable comparisons to the failed blood-testing company Theranos.
  • Helios arrives as academic research increasingly shows blood proteins can predict organ aging and disease years in advance, suggesting the science may finally be catching up to the consumer diagnostics ambitions that doomed earlier ventures.

Get the app

Stay Ahead With Velocity

Deep company profiles, investor context, and every original source behind this story — plus the next one, the moment it breaks.

Download on the App StoreGet it on Google Play

More This Week

View All →